SCHEMBL32676141

SCHEMBL32676141

O=Cc1ccc(N2CCCCCC2)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 11/20 0.51
MAPT P10636 3/20 0.51
KMT2A Q03164 3/20 0.51
PSMD14 O00487 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 3/20 0.46
TRIM24 O15164 1/20 0.42
TRIM33 Q9UPN9 1/20 0.42
POLB P06746 1/20 0.39
ALDH1A3 P47895 3/20 0.39
MEN1 O00255 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM1 P11229 1/20 0.37
CHRM3 P20309 1/20 0.37
ALOX12 P18054 1/20 0.36
CASP1 P29466 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260268 1.00 ALDH1A1 (0.51) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL8702014 0.98 ALDH1A1 (0.49) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL32676230 0.94 ALDH1A1 (0.44) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL50465 0.87 DPP4 (0.46) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL9915649 0.83 ALDH1A1 (0.50) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL31178703 0.82 CA2 (0.36) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL29574929 0.82 ALDH1A1 (0.46) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2
SCHEMBL1432800 0.81 ALDH1A1 (0.55) ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL1555679 0.81 TDP1 (0.51) ALDH1A1MAPTKMT2ASMN1; SMN2KDM4E
SCHEMBL1432603 0.81 AOC3 (0.40) ALDH1A1MAPTKMT2APSMD14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049073-A1 SPECTACLE LENS COMPRISING AN ORGANIC DYE OAKLEY, INC. (US) 2026-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049073-A1 SPECTACLE LENS COMPRISING AN ORGANIC DYE STRA6, TCOF1, CLIC1 ALDH1A1 873/4885MAPT 2539/4885KMT2A 3062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.